Severe Photosensitivity Reaction After Pirfenidone Use

Idiopathic pulmonary fibrosis is a chronic and progressive disease with a significant mortality rate. Pirfenidone is one of two oral antifibrotic therapies approved to treat idiopathic pulmonary fibrosis (IPF). Pirfenidone helps decrease disease progression in patients with IPF and reduces vital cap...

Descripción completa

Detalles Bibliográficos
Autores principales: Choudhury, Saiara, Taweesedt, Pahnwat T, Dadhwal, Rahul, Surani, Salim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Family/General Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384726/
https://www.ncbi.nlm.nih.gov/pubmed/34458037
http://dx.doi.org/10.7759/cureus.16626
Descripción
Sumario:Idiopathic pulmonary fibrosis is a chronic and progressive disease with a significant mortality rate. Pirfenidone is one of two oral antifibrotic therapies approved to treat idiopathic pulmonary fibrosis (IPF). Pirfenidone helps decrease disease progression in patients with IPF and reduces vital capacity. This has led to widespread use of this medication in recent years. In this case report, we present a 60-year-old male who started treatment with pirfenidone for IPF and had severe skin reactions after initiation of therapy.

Ejemplares similares